CCB

Collaboration in cancer logo

Working together: Collaboration in the cancer biobanking landscape

Working together: Collaboration in the cancer biobanking landscape On 17th October, the UKCRC TDCC attended the Confederation of Cancer Biobanks (CCB) and CM-Path’s joint meeting ‘Working together: Collaboration in the cancer biobanking landscape’. The day was a great opportunity to bring together colleagues from throughout the UK to discuss the challenges and opportunities currently developing in the Cancer landscape. Dr Phil Quinlan presenting UKCRC TDCC The Confederation of Cancer Biobanks… Read More »Working together: Collaboration in the cancer biobanking landscape

Biobanking expertise: Accreditation

Accreditation

Accreditation Review of the CCB’s pilot audit scheme Background Biobanking is recognised as a critical area requiring development if progress is to be made in identifying clinically useful markers of disease and disease progression, discovering new drug targets and understanding the mechanisms of disease in cancer. Researchers continue to report that they are unable to obtain sufficient high quality, well annotated samples of diseased and control tissue, blood and other… Read More »Accreditation